Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 18,500 shares at $58.48 ($1.1M) on 2019-12-18, disclosed to the SEC on 2019-12-20.
Open-market sale of $1.1M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.76 | 3,730 | $215K | 19.7% |
| 2 | $58.48 | 3,898 | $228K | 20.8% |
| 3 | $59.78 | 7,802 | $466K | 42.6% |
| 4 | $60.38 | 3,070 | $185K | 16.9% |
| Total | $59.20 avg | 18,500 | $1.1M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |